ComplianceOnline

Veterinary Medicine and the DEA Due Diligence Requirement for Dispensing and Prescribing a Controlled Substance

Instructor: Carlos M Aquino
Product ID: 704892
Training Level: Intermediate
  • Duration: 60 Min
Purchase option for this webinar is currently unavailable. Please contact our Customer Care for more info.

Customer Care

Fax: +1-650-963-2556

Email: customercare@complianceonline.com

Read Frequently Asked Questions

This webinar will discuss federal laws and regulations covering all veterinarians who dispense and prescribe controlled substances, record-keeping requirements, penalties for non-compliance and the DEA due diligence required.

Why Should You Attend:

The Drug Enforcement Administration (“DEA”) through their Office of Diversion Control (“Diversion”) is responsible for enforcing federal laws and DEA regulations pertaining to the administering, dispensing and prescribing of controlled substances by practitioners practicing veterinary medicine in a hospital, clinic or private office.

Three area of concern by practitioners in veterinary medicine are the record-keeping requirements, the security of controlled substances and the DEA Due Diligence required of all registrants who are dispensing and prescribing controlled substances.

The Controlled Substances Act is very clear on requirements for all veterinarian who dispense and prescribe controlled substance that such activity is done for legitimate medical purposes and that the practitioner is practicing in their professional field of medicine.

Areas Covered in the Webinar:

  • Identify the role of DEA and the steps taken by DEA Diversion to determine that any and all dispensing and prescribing of controlled substances are done for legitimate medical purpose.
  • Display the steps taken by DEA personnel when arriving at a hospital, clinic or private office of a practitioner in veterinary medicine to establish the legitimacy of a controlled substance dispense or prescribed for legitimate medical purpose but not used for the intended purpose resulting in diversion into the illicit market.
  • Describe the types of administrative or civil actions that can be imposed by DEA and federal prosecutor’s office for the dispensing, and prescribing of a controlled substance not intended for animal patients.
  • The need for practitioners practicing veterinary medicine to maintain complete and accurate medical charts for animal patients and the steps taken to identify the need for administering, dispensing or prescribing a controlled substance to such patients.
  • Requirement of practitioners practicing veterinary medicine to report any and all theft by employees and the diversion of a controlled substance meant for an animal patient. Such reporting is not only required by DEA but also state regulatory entities responsible for controlled substances.

Who Will Benefit:

All medical practitioners whose field of medicine is veterinary medicine, surgery or dentistry and animal health technicians who are supervised by such practitioners.

  • Veterinary medicine practitioners - physicians, surgeons, etc.
  • Compliance officers in clinics and medical offices
  • Pharmacists
  • Manufacturers of veterinary medicine
  • Distributors of veterinary medicine
  • Veterinarians and animal health technicians

Instructor Profile:

In January 2009, Carlos M. Aquino founded PharmaDiversion, LLC as a compliance consulting firm assisting DEA registrants, who handle controlled substances and regulated chemicals, with compliance of federal laws and regulations that are enforced by DEA through the Office of Diversion Control. This is done through a “Mock” audit and inspection equivalent to a DEA Diversion on-site inspection. The firm also provides in-service training on various areas pertaining to compliance with federal laws and DEA regulations for handling controlled substances.

Consultant Carlos M. Aquino brings 36 years of experience on handling illicit and pharmaceutical controlled substances and regulated chemicals. This includes 12 years with the Philadelphia DEA Diversion and 24 years with the Philadelphia Police Department. During the last 10 years, he was assigned to the Philadelphia DEA Task Force as a street supervisor, undercover agent and case agent investigating the distribution of illicit drugs and the diversion of pharmaceutical drugs.

Follow us :
ComplianceOnline Banking Summit 2016 | Risk Management and Data Security - 80390SEM
ComplianceOnline Medical Device Summit 2017

Product Reviews

This product hasn't received any reviews yet. Be the first to review this product! Write review

Best Sellers
You Recently Viewed
    Loading